Zhongnan Medical Journal Press

Home Results

A total of 52 result was found. Results that relate to Guideline

Revision process of the Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition)

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):121-135.
11410 times 1876 times

YAN Jinan WU Yunxiao NIE Xiaolu ZHAO Houyu ZHAN Siyan SUN Feng

Pharmacoepidemiological research Methodology Guidelines Expert consultation Consensus
Details
Methodology and report quality evaluation of multiple sclerosis guidelines and consensus

Published on New Medicine 2025,35(3):328-338.
11546 times 1973 times

HE Lanzhi ZHOU Xin ZHOU Pengxiang ZHAO Yingxue LUO Haikun ZHOU Ganping

Multiple sclerosis Guideline Consensus Methodology quality Report quality Quality evaluation
Details
Interpretation of the Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) (III): comparison of global guidelines

Published on Chinese Journal of Pharmacoepidemiology 2025,34(3):241-259.
10810 times 2225 times

YAN Jinan WU Yunxiao NIE Xiaolu ZHAO Houyu ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodological guideline Systematic review
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (4): sources of research question and study protocol development in pharmacoepidemiological research

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):365-372.
13070 times 3507 times

CHENG Yinchu HE Na YAN Yingying ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Research question Study protocol
Details
Evidence-based evaluation for guidelines or consensus on pediatric off-label medication

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):428-436.
14359 times 3941 times

PAN Zhenyu WANG Zhaojie CHENG Hua

Off-label medication Children Guidelines Consensus Evidence-based evaluation
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (5): classic study designs and derivative approaches

Published on Chinese Journal of Pharmacoepidemiology 2025,34(5):485-493.
17740 times 4121 times

ZHANG Yiying YIN Shiwenqian MENG Shuhan WANG Shanjie ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Classic research type Derivative design
Details
Implementation effect of the clinical practice guideline for type 2 diabetes mellitus in public hospitals in China: a cross-sectional study using the A-GIST tool

Published on New Medicine 2025,35(6):611-621.
10322 times 1845 times

HE Siyi ZOU Kun YANG Nan ZENG Linan LI Hailong HUANG Liang YI Qiusha ZENG Xiantao DU Liang GAO Xiangyu REN Jiajun HE Miao ZHANG Mingyue WANG Qiang ZHANG Lingli

Clinical practice guidelines Implementation effect Diabetes mellitus Cross-sectional study
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (7): selection of control groups

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):725-733.
11775 times 1879 times

TIAN Qinxi ZHAN Siyan SUN Feng YANG Zhirong

Pharmacoepidemiology Methodology Guidelines Control Interventional research Non-interventional research
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (11): introduction and examples of pharmacovigilance impact research

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1233-1243.
6139 times 1228 times

NIE Xiaolu SONG Haibo REN Jingtian YAN Jinan WU Jiarui ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Pharmacovigilance impact research
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (12): applications of negative control methods and case analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1353-1362.
3626 times 860 times

JIANG Baoyuan ZHAN Siyan SUN Feng YANG Zhirong WU Shanshan

Pharmacoepidemiology Methodology Guidelines Negative controls Unmeasured confounding
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (13): advances in the application and case studies of systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2026,35(1):2-16.
5057 times 916 times

DIAO Sha HU Yuanhui LIU Jianing LI Hailong ZOU Kun YANG Chunsong BO Zhenyan WEI Yuanxiu YANG Jiayi ZENG Linan ZHANG Lingli

Pharmacoepidemiology Methodology Guidelines Systematic review Meta-analysis
Details
Research on living clinical practice guidelines in diabetes mellitus Ⅰ: a qualitative study of public-oriented web-based knowledge platform and guideline dissemination

Published on New Medicine 2026,36(1):2-7.
4618 times 894 times

WANG Shichun WANG Wanru ZHU Shuqiong TAO Chuanfeng RUAN Siyuan ZHANG Qiyi LIU Tiansi TALIFU · Paerwenayi HUANG Qiao YOU Liangzhen TANG Jun JIN Yinghui

Diabetes mellitus Clinical practice guideline Platform construction Living guideline Qualitative research Interviews
Details
Applicability challenges and optimization strategies of guideline recommendations in multimorbidity management

Published on Chinese Journal of Pharmacoepidemiology 2026,35(3):336-345.
2563 times 604 times

ZHU Shuqiong TALIFU Paerwenayi RUAN Siyuan GAO Feng YOU Liangzhen WANG Yongbo YAN Siyu HUANG Qiao REN Xiangying JIN Yinghui

Multimorbidity Clinical practice guideline Recommendation Real-world evidence Artificial intelligence
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (14): research designs and case studies of target trial emulation

Published on Chinese Journal of Pharmacoepidemiology 2026,35(2):121-132.
4492 times 878 times

ZHAO Houyu CHENG Yinchu SUN Feng ZHAN Siyan

Target trial emulation Pharmacoepidemiology Methodology Guidelines Active comparator new-user design Sequential trial Clone-censor-weight
Details
Quality evaluation of guidelines, consensus and statements related to cardiovascular diseases

Published on Journal of Mathematical Medicine 2026,39(2):141-151.
4456 times 807 times

QIAN Shichao YANG Yazhuo MEN Jiakun BAI Zhenggang

Cardiovascular diseases Guidelines Consensus Statements Quality evaluation AGREE Ⅱ RIGHT
Details